JRN73958
JRN73958 (Reduced scytonemin) is a PI3K/Akt, MAPK, and NF-κB inhibitor found in Nostoc commune. JRN73958 inhibits nitric oxide production, induce reactive oxygen species (ROS) generation, and lead to autophagy. JRN73958 decreases LPS (HY-D1056)/IFNγ-induced PI3K/Akt, MAPK, and NF-κB activity. JRN73958 can be used for the research of leukemia.
For research use only. We do not sell to patients.
- CAS No.: 171773-95-8
- Formula: C36H24N2O4
- Molecular Weight:548.59
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
JRN73958 (0.5-2.5 μM; 2 h pretreatment) suppresses LPS/IFNγ-induced NO production in murine macrophage RAW264 cells in a concentration-dependent manner, with the strongest inhibition observed at 2.5 μM[1].
JRN73958 (2.5 μM; 2 h pretreatment) significantly reduces LPS/IFNγ-induced iNOS and COX-2 mRNA and protein expression in murine macrophage RAW264 cells[1].
JRN73958 (2.5 μM; 2 h pretreatment) inhibits LPS/IFNγ-mediated activation of p38 MAPK, ERK, SAPK/JNK, IκB, and STAT1 in murine macrophage RAW264 cells[1].
JRN73958 (2.5 μM; 2 h pretreatment) increases HO-1 expression 3.5-fold in murine macrophage RAW264 cells, and this induction is required for JRN73958's inhibitory effect on LPS/IFNγ-induced NO production[1].
JRN73958 (2.5 μM; 15-120 min) transiently increases intracellular ROS levels in murine macrophage RAW264 cells, reaching a 1.8-fold peak at 30 min[1].
JRN73958 (2.5 μM; 24 h) activates Nrf2/ARE signaling in murine macrophage RAW264 cells, increasing ARE enhancer activity to 1.35-fold relative to untreated cells[1].
JRN73958 (2.5 μM; 2 h) has its induced HO-1 expression in murine macrophage RAW264 cells suppressed by pretreatment with the antioxidant NAC or the kinase inhibitors SB203580 and LY294002[1].
JRN73958 (2.5 μM; 5-120 min pretreatment) activates p38 MAPK and PI3K/Akt signaling in murine macrophage RAW264 cells, with peak phosphorylation observed at 30 min[1].
JRN73958 (1.0-5.0 μM; 24-72 h) inhibits the growth of human T-lymphoid Jurkat cells with an IC50 of 1.8 μM[2].
JRN73958 (2.5 μM; 3-12 h) induces nuclear swelling, nuclear fragmentation, and reduced mitochondrial membrane potential in human T-lymphoid Jurkat cells[2].
JRN73958 (2.5-5.0 μM; 6-24 h) induces only marginal nucleosomal DNA fragmentation in human T-lymphoid Jurkat cells[2].
JRN73958 (2.5 μM; 72 h) induces human T-lymphoid Jurkat cell death that is resistant to caspase-8, caspase-9, and pan-caspase inhibitors after 72 h of treatment[2].
JRN73958 (2.5 μM; 12 h) induces the formation of multiple vacuoles and autophagosomes in human T-lymphoid Jurkat cells after 12 h of treatment[2].
JRN73958 (2.5 μM; 6-24 h) induces the conversion of LC3-I to LC3-II, a marker of autophagy, in human T-lymphoid Jurkat cells after 6, 12, and 24 h of treatment[2].
JRN73958 (2.5 μM; 12 h) induces colocalization of LC3 and lysosomes, marking autophagosome/autolysosome formation, in human T-lymphoid Jurkat cells after 12 h of treatment[2].
JRN73958 (2.5 μM; 48 h) induces autophagic cell growth inhibition in human T-lymphoid Jurkat cells after 48 h of treatment, which is reversible by the autophagy inhibitor 3-MA[2].
JRN73958 (2.5 μM; 48 h) induces human T-lymphoid Jurkat cell growth inhibition after 48 h of treatment, which is reversible by the antioxidant NAC[2].
JRN73958 (2.5 μM; 0.5-24 h) inhibits Akt phosphorylation in a time-dependent manner in human T-lymphoid Jurkat cells over 0.5, 1, 3, 6, 12, and 24 h of treatment[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:murine macrophage RAW264 cells
-
Concentration:2.5 μM
-
Incubation Time:2 h
-
Result:Remarkably suppressed LPS/IFNγ-stimulated p38 MAPK and ERK activation.
Slightly suppressed SAPK/JNK and IκB activation up to 30 and 60 min respectively.
Strongly suppressed STAT1 activation.
-
Cell Line:human T-lymphoid Jurkat cells
-
Concentration:2.5 μM
-
Incubation Time:6 h; 12 h; 24 h
-
Result:Increased levels of both LC3-I and LC3-II in Jurkat cells up to 24 h after treatment, indicating conversion of LC3-I to LC3-II.
-
Cell Line:human T-lymphoid Jurkat cells
-
Concentration:2.5 μM
-
Incubation Time:48 h
-
Result:Induced autophagic cell growth inhibition that was significantly blocked by the autophagy inhibitor 3-MA.\nInduced Jurkat cell growth inhibition that was reversed by pretreatment with the antioxidant NAC.
-
Cell Line:human T-lymphoid Jurkat cells
-
Concentration:2.5 μM
-
Incubation Time:0.5 h; 1 h; 3 h; 6 h; 12 h; 24 h
-
Result:Inhibited phosphorylation of Akt in a time-dependent manner, with reduced p-Akt levels observed from 0.5 h onwards.
Chemical Information
-
CAS No. 171773-95-8
-
Molecular Weight 548.59
-
Formula C36H24N2O4
-
SMILES
O=C1/C(C2NC3=C(C2=C1C(C/4=O)=C5C6=C(C=CC=C6)NC5C4=C\C7=CC=C(C=C7)O)C=CC=C3)=C\C8=CC=C(C=C8)O
-
Synonyms
Reduced scytonemin
-
Structure Classification
-
Initial Source
Lyngbya sp. CU2555
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
Purity & Documentation
References
[1]. Itoh T, et al. Reduced scytonemin isolated from Nostoc commune suppresses LPS/IFNγ-induced NO production in murine macrophage RAW264 cells by inducing hemeoxygenase-1 expression via the Nrf2/ARE pathway. Food Chem Toxicol. 2014;69:330-338. [Content Brief]
[2]. Itoh T, et al. Reduced scytonemin isolated from Nostoc commune induces autophagic cell death in human T-lymphoid cell line Jurkat cells. Food Chem Toxicol. 2013;60:76-82. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)